Literature DB >> 24132662

Endotoxin tolerance induced by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli: alternations in Toll-like receptor 2 and 4 signaling pathway.

Ying Sun1, Hui Li, Meng-Jun Sun, Yang-Yu Zheng, Dan-Jun Gong, Yan Xu.   

Abstract

Periodontitis is a chronic inflammatory disease induced by bacteria. Exposure of the host to periodontal pathogens and their virulence factors induces a hyporesponsive state to subsequent challenge, which is termed endotoxin tolerance. In this experiment, we studied the cytokine production in THP-1 cells upon single or repeated Porphyromonas gingivalis (P. gingivalis) lipopolysaccharide (LPS) or Escherichia coli (E. coli) LPS stimulation by ELISA. In addition, the protein expression profiles of Toll-like receptor 2 (TLR2), TLR4, IL-1 receptor-associated kinase 4 (IRAK4) and IRAK-M and the gene expression changes of Toll-interacting protein (Tollip) and suppressor of cytokine-signaling-1 (SOCS1) were explored to identify possible mechanisms for changes in cytokine secretion. After repeated stimulation with P. gingivalis LPS or E. coli LPS, secretions of TNF-α and IL-1β were decreased significantly compared with those following single challenge, while the levels of IL-10 were increased (p < 0.05). Only comparable levels of IL-8 were confirmed in P. gingivalis LPS-tolerized cells (p > 0.05). In addition, severe downregulation of TLR2 was detected in THP-1 cells retreated with P. gingivalis LPS, and the reduction of TLR4 expression was observed in cells restimulated with E. coli LPS (p < 0.05). Precondition with P. gingivalis LPS or E. coli LPS also led to an enhancement of IRAK-M and SOCS1, while maintaining the expressions of IRAK4 and Tollip. This pattern of cytokine production indicates the different effects of endotoxin tolerance triggered by P. gingivalis LPS and E. coli LPS, which might contribute to limiting inflammatory damage. Moreover, TLR2, TLR4, IRAK-M, and SOCS1 might play important roles in developing tolerance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24132662     DOI: 10.1007/s10753-013-9737-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  39 in total

1.  Detection of Fusobacterium nucleatum in chorionic tissues of high-risk pregnant women.

Authors:  Fumi Tateishi; Kozue Hasegawa-Nakamura; Toshiaki Nakamura; Yuichi Oogai; Hitoshi Komatsuzawa; Kazuya Kawamata; Tsutomu Douchi; Masayuki Hatae; Kazuyuki Noguchi
Journal:  J Clin Periodontol       Date:  2012-02-06       Impact factor: 8.728

Review 2.  Microbial etiological agents of destructive periodontal diseases.

Authors:  A D Haffajee; S S Socransky
Journal:  Periodontol 2000       Date:  1994-06       Impact factor: 7.589

3.  Gram-negative periodontal bacteria induce the activation of Toll-like receptors 2 and 4, and cytokine production in human periodontal ligament cells.

Authors:  Ying Sun; Rong Shu; Chao-Lun Li; Ming-Zhu Zhang
Journal:  J Periodontol       Date:  2010-10       Impact factor: 6.993

4.  Altered Toll-like receptor 2-mediated endotoxin tolerance is related to diminished interferon beta production.

Authors:  Svetislav S Zaric; Wilson A Coulter; Charles E Shelburne; Catherine R Fulton; Marija S Zaric; Aaron Scott; Mark J Lappin; Denise C Fitzgerald; Christopher R Irwin; Clifford C Taggart
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

Review 5.  Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints.

Authors:  G P Garlet
Journal:  J Dent Res       Date:  2010-08-25       Impact factor: 6.116

6.  Actinobacillus actinomycetemcomitans lipopolysaccharide stimulates the phosphorylation of p44 and p42 MAP kinases through CD14 and TLR-4 receptor activation in human gingival fibroblasts.

Authors:  Gloria Gutiérrez-Venegas; Perla Kawasaki-Cárdenas; Santa Rita Cruz-Arroyo; Miguel Pérez-Garzón; Silvia Maldonado-Frías
Journal:  Life Sci       Date:  2005-11-28       Impact factor: 5.037

7.  Periodontal diseases in the United States population.

Authors:  R C Oliver; L J Brown; H Löe
Journal:  J Periodontol       Date:  1998-02       Impact factor: 6.993

8.  Peroxisome proliferator activated receptor gamma is not necessary for the development of LPS-induced tolerance in macrophages.

Authors:  Basilia Zingarelli; Hongkuan Fan; Sarah Ashton; Giovanna Piraino; Prajakta Mangeshkar; James A Cook
Journal:  Immunology       Date:  2007-11-17       Impact factor: 7.397

9.  Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.

Authors:  Andrei E Medvedev; Wenji Piao; Joanna Shoenfelt; Sang Hoon Rhee; Haiyan Chen; Subhendu Basu; Larry M Wahl; Matthew J Fenton; Stefanie N Vogel
Journal:  J Biol Chem       Date:  2007-03-28       Impact factor: 5.157

Review 10.  Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins.

Authors:  Ioannis D Dimitriou; Liliana Clemenza; Andrew J Scotter; Grace Chen; Fiona M Guerra; Robert Rottapel
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

View more
  13 in total

Review 1.  Arterial Catheterization and Infection: Toll-like Receptors in Defense against Microorganisms and Therapeutic Implications.

Authors:  Zakary J Hambsch; Mitchell J Kerfeld; Daniel R Kirkpatrick; Dan M McEntire; Mark D Reisbig; Charles F Youngblood; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2015-08-14       Impact factor: 4.689

2.  SMAD4 is Involved in the Development of Endotoxin Tolerance in Microglia.

Authors:  Xiaorong Liu; Yongwei Qin; Aihua Dai; Yu Zhang; Huaqing Xue; Haidan Ni; Lijian Han; Liang Zhu; Debin Yuan; Tao Tao; Maohong Cao
Journal:  Cell Mol Neurobiol       Date:  2016-01-12       Impact factor: 5.046

3.  Macrophage subsets exhibit distinct E. coli-LPS tolerisable cytokines associated with the negative regulators, IRAK-M and Tollip.

Authors:  Khalid Al-Shaghdali; Barbara Durante; Christopher Hayward; Jane Beal; Andrew Foey
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

4.  Effects of Endotoxin Tolerance Induced by Porphyromonas gingivalis Lipopolysaccharide on Inflammatory Responses in Neutrophils.

Authors:  Jian-Yu Gu; Yu-Jie Liu; Xiang-Qing Zhu; Jia-Ying Qiu; Ying Sun
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

5.  Compromised inflammatory cytokine response to P. gingivalis LPS by fibroblasts from inflamed human gingiva.

Authors:  Tracy R Fitzsimmons; Shaohua Ge; P Mark Bartold
Journal:  Clin Oral Investig       Date:  2017-07-08       Impact factor: 3.573

6.  Effects of Porphyromonas gingivalis LipopolysaccharideTolerized Monocytes on Inflammatory Responses in Neutrophils.

Authors:  Xiang-Qing Zhu; Wei Lu; Yang Chen; Xiao-Fan Cheng; Jia-Ying Qiu; Yan Xu; Ying Sun
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

7.  Ligature-induced periodontitis induces systemic inflammation but does not alter acute outcome after stroke in mice.

Authors:  Conor O'Boyle; Michael J Haley; Eloise Lemarchand; Craig J Smith; Stuart M Allan; Joanne E Konkel; Catherine B Lawrence
Journal:  Int J Stroke       Date:  2019-02-22       Impact factor: 5.266

8.  Placental extracellular vesicles-associated microRNA-519c mediates endotoxin adaptation in pregnancy.

Authors:  Caterina Tiozzo; Mark Bustoros; Xinhua Lin; Claudia Manzano De Mejia; Ellen Gurzenda; Martin Chavez; Iman Hanna; Paola Aguiari; Laura Perin; Nazeeh Hanna
Journal:  Am J Obstet Gynecol       Date:  2021-06-26       Impact factor: 8.661

9.  Anti-inflammatory effects of low-level laser therapy on human periodontal ligament cells: in vitro study.

Authors:  Ji-Hua Lee; Min-Hsuan Chiang; Ping-Ho Chen; Mei-Ling Ho; Huey-Er Lee; Yan-Hsiung Wang
Journal:  Lasers Med Sci       Date:  2017-11-07       Impact factor: 3.161

10.  Tolerance induced by Porphyromonas gingivalis may occur independently of TLR2 and TLR4.

Authors:  Wei Lu; Jian-Yu Gu; Yao-Yao Zhang; Dan-Jun Gong; Yi-Ming Zhu; Ying Sun
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.